DBV Technologies is a clinical-stage biopharmaceutical company based in France that develops treatments for food allergies. Its work centres on epicutaneous immunotherapy, a technique that delivers allergens through the skin using its Viaskin patch system. The company's main programmes address peanut allergy, especially in children, and it also studies other food allergies. Its customers would be patients, caregivers and healthcare providers, while development is carried out with clinical investigators and regulators.
On this site DBV Technologies appears as a stock on the London Stock Exchange (UK), code 0QAJ, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3660 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
6/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-37.0%
From 52-week high-56.4%
MomentumWeak
9/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-24.2%
6-month return-47.0%
12-month, skipping last month-28.4%
Stability (higher is calmer)Weak
14/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)64.3%
Worst drawdown, 1 year (smaller is calmer)-63.3%
LiquidityWeak
21/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.04M EUR
Zero-volume days5.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 1.565 – 4.460Daily closes, split-adjusted
Signals
50-day average2.065
200-day average2.955
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.195
Technical summary
Daily
Neutral
5 bullish · 4 neutral · 7 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
1.69
Bullish
EMA 10
1.75
Bullish
SMA 20
1.75
Bullish
EMA 20
1.79
Bullish
SMA 50
2.07
Bearish
EMA 50
2.02
Bearish
SMA 100
2.36
Bearish
EMA 100
2.31
Bearish
SMA 200
2.96
Bearish
EMA 200
2.52
Bearish
Oscillators (daily)
RSI (14)
51.16
Neutral
MACD (12, 26)
-0.09
Bearish
Momentum (12)
9.76
Bullish
Stochastic %K (14)
38.83
Neutral
Williams %R (14)
-61.17
Neutral
CCI (20)
14.09
Neutral
Pivot points (classic, last session)
S3
1.67
S2
1.71
S1
1.78
Pivot
1.82
R1
1.90
R2
1.94
R3
2.01
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
